What is MabCampath?
This is a summary of the European public assessment report (EPAR) for MabCampath. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for MabCampath.
What is MabCampath used for?
MabCampath is a concentrate that is made up noi to a solution for infusion (drip into a vein). It contains the active substanceproductalemtuzumab (10 mg/ml or 30 mg/ml).
MabCampath is used to treat patients with
MedicinalThe medicine can on y be obtained with a prescription.
How is M bC mpath used?
MabCampath treatment should be supervised by a doctor experienced in the use of cancer treatments. Pat ents should be given steroids, an antihistamine and a painkiller before the first dose and before any
rease in dose. They should also receive antibiotics and antiviral medicines during and after